CSIMarket
 


Merck and Co Inc   (MRK)
Other Ticker:  
 
 

MRK's Net Cash Flow Growth by Quarter and Year

Merck And Co Inc 's Net Cash Flow results by quarter and year




MRK Net Cash Flow (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December 0.00 1,494.00 -1,879.00 764.00
III Quarter September 2,957.00 1,526.00 1,416.00 -3,746.00
II Quarter June -4,074.00 1,139.00 1,619.00 3,687.00
I Quarter March -2,987.00 447.00 -1,142.00 -2,474.00
FY   -4,104.00 4,606.00 14.00 -1,769.00



MRK Net Cash Flow fourth quarter 2023 Y/Y Growth Comment
Merck and Co Inc in the fourth quarter 2023 recorded net cash outflow of $ 0.00 millions.

Looking into fourth quarter 2023 results within Major Pharmaceutical Preparations industry 7 other companies have achieved higher Net Cash Flow growth. While Merck And Co Inc ' s Net Cash Flow no change of % ranks overall at the positon no. 240 in the fourth quarter 2023.




MRK Net Cash Flow ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -61.16 %
III Quarter September 93.77 % 7.77 % - -
II Quarter June - -29.65 % -56.09 % -
I Quarter March - - - -
FY   - 32800 % - -

Financial Statements
Merck And Co Inc 's fourth quarter 2023 Net Cash Flow $ 0.00 millions MRK's Income Statement
Merck And Co Inc 's fourth quarter 2022 Net Cash Flow $ 1,494.00 millions Quarterly MRK's Income Statement
New: More MRK's historic Net Cash Flow Growth >>


MRK Net Cash Flow (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - -2.1 % - -
III Quarter September - 33.98 % -12.54 % -
II Quarter June - 154.81 % - -
I Quarter March - - - -
FY (Year on Year)   - 32800 % - -




Net Cash Flow fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #8
Healthcare Sector #22
Overall #240

Net Cash Flow Y/Y Growth Statistics
High Average Low
32800 % 1120.82 % -513.3 %
(Dec 31 2022)   (Sep. 30, 2007)
Net Cash Flow fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #8
Healthcare Sector #22
Overall #240
Net Cash Flow Y/Y Growth Statistics
High Average Low
32800 % 1120.82 % -513.3 %
(Dec 31 2022)   (Sep. 30, 2007)

Net Cash Flow by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Merck And Co Inc 's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


MRK's IV. Quarter Q/Q Net Cash Flow Comment
Current results of 0.00 millions by Merck and Co Inc look even more unfavourable considering the 2,957.00 millions a quarter before.

Within Major Pharmaceutical Preparations industry Merck and Co Inc achieved highest sequential Net Cash Flow growth. While Merck And Co Inc 's Net Cash Flow growth quarter on quarter, overall rank is .


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


MRK's IV. Quarter Q/Q Net Cash Flow Comment
IV. Quarter 2023 results of 0.00 millions by Merck and Co Inc appear even more unfavourable if you take a look at 2,957.00 millions net cash outflow in the previous quarter.

Within Major Pharmaceutical Preparations industry Merck and Co Inc achieved highest sequential Net Cash Flow growth. While Merck And Co Inc 's Net Cash Flow growth quarter on quarter, overall rank is .


Merck And Co Inc 's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Net Cash Flow 12 Months Ending $ -2,610.00 $ -4,041.00 $ 1,172.00 $ 4,606.00 $ 1,233.00
Y / Y Net Cash Flow Growth (TTM) - - -26.89 % 32800 % -53.59 %
Year on Year Net Cash Flow Growth Overall Ranking # 307 # 467 # 256 # 0 # 476
Seqeuential Net Cash Flow Change (TTM) - - -74.55 % 273.56 % 9.8 %
Seq. Net Cash Flow Growth (TTM) Overall Ranking # 240 # 342 # 2 # 0 # 547




Cumulative Net Cash Flow growth Comment
Merck And Co Inc realized trailing twelve months net cash outflow of $ -2,610 millions, in the Sep 30 2023, compare to Net Cash Flow of $ 1,233 millions a year ago.

Within the Healthcare sector 27 other companies have achieved higher trailing twelve month Net Cash Flow growth. While Total ranking has impoved so far to 307, from total ranking in previous quarter at 467.

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
32800 %
1120.82 %
-513.3 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 8
Healthcare Sector # 28
Overall # 307

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
32800 %
1120.82 %
-513.3 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 8
Sector # 22
S&P 500 # 240
Cumulative Net Cash Flow growth Comment
Merck And Co Inc realized trailing twelve months net cash outflow of $ -2,610 millions, in the Sep 30 2023, compare to Net Cash Flow of $ 1,233 millions a year ago.

Within the Healthcare sector 27 other companies have achieved higher trailing twelve month Net Cash Flow growth. While Total ranking has impoved so far to 307, from total ranking in previous quarter at 467.

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
32800 %
1120.82 %
-513.3 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 8
Healthcare Sector # 28
Overall # 307

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
32800 %
1120.82 %
-513.3 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 8
Sector # 22
S&P 500 # 240




Other Net Cash Flow Growth
Major Pharmaceutical Preparations Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
MRK's Net Cash Flow Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for MRK's Competitors
Net Cash Flow Growth for Merck And Co Inc 's Suppliers
Net Cash Flow Growth for MRK's Customers

You may also want to know
MRK's Annual Growth Rates MRK's Profitability Ratios MRK's Asset Turnover Ratio MRK's Dividend Growth
MRK's Roe MRK's Valuation Ratios MRK's Financial Strength Ratios MRK's Dividend Payout Ratio
MRK's Roa MRK's Inventory Turnover Ratio MRK's Growth Rates MRK's Dividend Comparisons



Companies with similar Net Cash Flow no change for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Dec 31 2023
Astrazeneca Plc-5.29%$ -5.287 millions
Lipocine Inc -6.98%$ -6.984 millions
Caredx Inc -14.62%$ -14.617 millions
Sophia Genetics Sa-16.41%$ -16.406 millions
Xencor Inc-17.78%$ -17.780 millions
Kronos Bio Inc -20.78%$ -20.784 millions
Earth Science Tech Inc -21.38%$ -21.381 millions
Hookipa Pharma inc -22.19%$ -22.193 millions
Anaptysbio Inc -24.22%$ -24.222 millions
Koru Medical Systems Inc-26.57%$ -26.570 millions
Abbott Laboratories-35.07%$ -35.069 millions
Lantheus Holdings Inc -37.16%$ -37.161 millions
Alcon inc -37.78%$ -37.778 millions
Inflarx N v -38.04%$ -38.037 millions
Novartis Ag-39.41%$ -39.413 millions
Argenx se-40.00%$ -40.005 millions
Gh Research Plc-40.04%$ -40.040 millions
Bright Minds Biosciences Inc -41.15%$ -41.154 millions
Enzon Pharmaceuticals inc -42.33%$ -42.332 millions
Myriad Genetics Inc -44.65%$ -44.653 millions
Elutia inc -46.46%$ -46.456 millions
Gilead Sciences Inc -46.70%$ -46.704 millions
Koninklijke Philips Nv-49.11%$ -49.110 millions
Avidity Biosciences Inc -49.45%$ -49.449 millions
Proqr Therapeutics N v -49.46%$ -49.460 millions
Protalix Biotherapeutics inc -49.52%$ -49.523 millions
Xeris Biopharma Holdings Inc -49.99%$ -49.994 millions
Altair International Corp -52.34%$ -52.344 millions
Macrogenics Inc -55.57%$ -55.574 millions
Atricure Inc -59.98%$ -59.983 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com